Cyclic kinase 4 and 6 inhibitor plus endocrine therapy (ET) as first-line therapies in advanced breast cancer: A patientlevel data network meta-analysis

Category Systematic review
ConferenceEuropean Society For Medical Oncology Asia Congress, ESMO Asia 2025
Year 2025
This article has no abstract
Epistemonikos ID: ec747442f555ba75521b44ae94cb22a15b55be1f
First added on: Feb 28, 2026